X0306 4 2022-09-15 0001635088 Roivant Sciences Ltd. ROIV 0001643073 Oren Ilan C/O ROIVANT SCIENCES LTD. 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL LONDON X0 SW1Y 4LB UNITED KINGDOM true Common Shares 2022-09-15 4 A 0 52142 0 A 55365 D Stock Option (Right to Buy) 3.5 2022-09-15 4 A 0 71850 0 A 2032-09-14 Common Shares 71850 71850 D Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date. By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren 2022-09-19